Position
Caption Management, LLC in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $9.81K$21.52 → $21.76
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 40.9K | $880K | — | — | — | 0.0% |
| Q1 2026 | 57.9K | $1.26M | $21.76 | $9.81K | $369.9K | 0.0% |